Mechanisms regulating colorectal cancer cell metastasis into liver (Review)

Jin,Ketao; Gao,Weili; Lu,Yanyan; Lan,Huanrong; Teng,Lisong; Cao,Feilin

doi:10.3892/ol.2011.432

Mechanisms regulating colorectal cancer cell metastasis into liver (Review)

Authors:
- Ketao Jin
- Weili Gao
- Yanyan Lu
- Huanrong Lan
- Lisong Teng
- Feilin Cao
View Affiliations

Affiliations: Department of Surgical Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang 317000, P.R. China, Department of Surgical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Gynecology and Obstetrics, Affiliated Zhuji Hospital, Wenzhou Medical College, Zhuji, Zhejiang 310003, P.R. China
Published online on: September 30, 2011 https://doi.org/10.3892/ol.2011.432
Pages: 11-15

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The metastatic spread of tumor cells is one of the most common causes of mortality in cancer patients. The elucidation of the molecular mechanisms that underlie the formation of metastatic colonies has been one of the major objectives of cancer research. Organ-specific colonization of cancer cells is a significant and noteworthy feature of metastasis. Colorectal cancer (CRC) is one of the most common causes of cancer-related mortality. The liver is commonly the sole site of metastasis for CRC and represents a major cause of mortality in CRC patients. However, what regulates CRC cell metastasis into liver and the reasons for the liver-specific metastasis of CRC have yet to be adequately elucidated. Recent progress provides indications and a conceptual framework with which to investigate this issue. This review evaluated experimental and clinical evidence to support a mechanistic role for circulation patterns and microvessels in liver, metastasis-related genes, chemokines and their receptors, and cellular adhesion molecules in the process of CRC liver metastasis.

View Figures

View References

1	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
2	Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 50:6130–6138. 1990.PubMed/NCBI
3	Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI
4	Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003.
5	Lu X and Kang Y: Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia. 12:153–162. 2007. View Article : Google Scholar : PubMed/NCBI
6	Horak CE and Steeg PS: Metastasis gets site specific. Cancer Cell. 8:93–95. 2005. View Article : Google Scholar : PubMed/NCBI
7	Nguyen DX, Bos PD and Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
8	Fisher ER and Turnbull RB Jr: The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet. 100:102–108. 1955.PubMed/NCBI
9	Fisher ER and Fisher B: Experimental studies of factors influencing the development of hepatic metastases. Xiii Effect of hepatic trauma in parabiotic pairs. Cancer Res. 23:896–900. 1963.PubMed/NCBI
10	Paku S, Döme B, Tóth R and Timár J: Organ-specificity of the extravasation process: an ultrastructural study. Clin Exp Metastasis. 18:481–492. 2000. View Article : Google Scholar : PubMed/NCBI
11	Lalor PF, Lai WK, Curbishley SM, Shetty S and Adams DH: Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol. 12:5429–5439. 2006.
12	Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R and Abbruzzese JL: Metastatic patterns in adenocarcinoma. Cancer. 106:1624–1633. 2006. View Article : Google Scholar : PubMed/NCBI
13	Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA and Massagué J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
14	Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M and Kelly K: Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol. 27:7538–7550. 2007. View Article : Google Scholar : PubMed/NCBI
15	Haier J and Nicolson GL: Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS. 109:241–262. 2001. View Article : Google Scholar : PubMed/NCBI
16	Hahn E, Wick G, Pencev D and Timpl R: Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut. 21:63–71, 198.
17	Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbé E and Vermoesen A: Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol. 24:100–111. 1996. View Article : Google Scholar
18	Tamkun JW and Hynes RO: Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem. 258:4641–4647. 1983.PubMed/NCBI
19	Kemperman H, Wijnands YM and Roos E: alphaV Integrins on HT-29 colon carcinoma cells: adhesion to fibronectin is mediated solely by small amounts of alphaVbeta6, and alphaVbeta5 is codistributed with actin fibers. Exp Cell Res. 234:156–164. 1997. View Article : Google Scholar : PubMed/NCBI
20	Haier J, Nasralla M and Nicolson GL: Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Br J Cancer. 80:1867–1874. 1999. View Article : Google Scholar
21	Kemperman H, Wijnands Y, Meijne AM and Roos E: TA3/St, but not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhes Commun. 2:45–58. 1994. View Article : Google Scholar : PubMed/NCBI
22	Roos E, Dingemans KP, Van de Pavert IV and Van den Bergh-Weerman MA: Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Br J Cancer. 38:88–99. 1978. View Article : Google Scholar : PubMed/NCBI
23	Trutmann M and Sasse D: The lymphatics of the liver. Anat Embryol (Berl). 190:201–209. 1994. View Article : Google Scholar : PubMed/NCBI
24	Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta. 948:175–224. 1988.PubMed/NCBI
25	Eble JA and Haier J: Integrins in cancer treatment. Curr Cancer Drug Targets. 6:89–105. 2006. View Article : Google Scholar
26	Gooding JM, Yap KL and Ikura M: The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays. 26:497–511. 2004. View Article : Google Scholar : PubMed/NCBI
27	Silbert JE and Sugumaran G: A starting place for the road to function. Glycoconj J. 19:227–237. 2002. View Article : Google Scholar : PubMed/NCBI
28	Weiss L: Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 11:227–235. 1992. View Article : Google Scholar : PubMed/NCBI
29	Haier J, Nasralla M and Nicolson GL: Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg. 231:11–24. 2000. View Article : Google Scholar : PubMed/NCBI
30	Schlüter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, Hölzen J and Haier J: Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol. 169:1064–1073. 2006.PubMed/NCBI
31	Juliano RL and Varner JA: Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol. 5:812–818. 1993. View Article : Google Scholar : PubMed/NCBI
32	Hulleman E and Boonstra J: Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci. 58:80–93. 2001. View Article : Google Scholar : PubMed/NCBI
33	Kikkawa H, Kaihou M, Horaguchi N, Uchida T, Imafuku H, Takiguchi A, Yamazaki Y, Koike C, Kuruto R, Kakiuchi T, et al: Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis. 19:717–725. 2002. View Article : Google Scholar : PubMed/NCBI
34	Enns A, Korb T, Schlüter K, Gassmann P, Spiegel HU, Senninger N, Mitjans F and Haier J: Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer. 41:1065–1072. 2005. View Article : Google Scholar : PubMed/NCBI
35	Enns A, Gassmann P, Schlüter K, Korb T, Spiegel HU, Senninger N and Haier J: Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg. 8:1049–1059. 2004. View Article : Google Scholar : PubMed/NCBI
36	Haier J, Nasralla MY and Nicolson GL: Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow. Clin Exp Metastasis. 17:377–387. 1999. View Article : Google Scholar : PubMed/NCBI
37	Okazaki K, Nakayama Y, Shibao K, Hirata K, Nagata N and Itoh H: Enhancement of metastatic activity of colon cancer as influenced by expression of cell surface antigens. J Surg Res. 78:78–84. 1998. View Article : Google Scholar : PubMed/NCBI
38	Konno A, Hoshino Y, Terashima S, Motoki R and Kawaguchi T: Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis. 19:61–70. 2002. View Article : Google Scholar : PubMed/NCBI
39	Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
40	Erez N and Coussens LM: Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer. 128:2536–2544. 2011. View Article : Google Scholar : PubMed/NCBI
41	Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL and Hoon DS: Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 244:113–120. 2006. View Article : Google Scholar : PubMed/NCBI
42	Günther K, Leier J, Henning G, Dimmler A, Weissbach R, Hohenberger W and Förster R: Prediction of lymph node meta-stasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer. 116:726–733. 2005.PubMed/NCBI
43	Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol. 23:2744–2753. 2005. View Article : Google Scholar : PubMed/NCBI
44	Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, et al: Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother. 54:781–791. 2005. View Article : Google Scholar : PubMed/NCBI
45	Zeelenberg IS, Ruuls-Van Stalle L and Roos E: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63:3833–3839. 2003.PubMed/NCBI
46	Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C and Keilholz U: Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol. 24:1910–1916. 2006. View Article : Google Scholar : PubMed/NCBI
47	Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, Kruse B, Konig J and Schilling M: Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol. 27:166–174. 2006. View Article : Google Scholar : PubMed/NCBI
48	Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, Aoki M and Taketo MM: Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci USA. 107:13063–13068. 2010. View Article : Google Scholar : PubMed/NCBI
49	Coukos G and Rubin SC: Chemotherapy resistance in ovarian cancer: new molecular perspectives. Obstet Gynecol. 91:783–792. 1998. View Article : Google Scholar : PubMed/NCBI
50	Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, et al: Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
51	Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ and Kim KK: KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res. 64:4235–4243. 2004. View Article : Google Scholar : PubMed/NCBI
52	Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW and Vogelstein B: A phosphatase associated with metastasis of colorectal cancer. Science. 294:1343–1346. 2001. View Article : Google Scholar : PubMed/NCBI
53	Kato H, Semba S, Miskad UA, Seo Y, Kasuga M and Yokozaki H: High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res. 10:7318–7328. 2004. View Article : Google Scholar : PubMed/NCBI
54	Zeng Q, Dong JM, Guo K, Li J, Tan HX, Koh V, Pallen CJ, Manser E and Hong W: PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 63:2716–2722. 2003.PubMed/NCBI
55	Fiordalisi JJ, Keller PJ and Cox AD: PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 66:3153–3161. 2006. View Article : Google Scholar : PubMed/NCBI
56	Li J, Guo K, Koh VW, Tang JP, Gan BQ, Shi H, Li HX and Zeng Q: Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. Clin Cancer Res. 11:2195–2204. 2005. View Article : Google Scholar : PubMed/NCBI
57	Miyamoto S, Nakamura M, Shitara K, Nakamura K, Ohki Y, Ishii G, Goya M, Kodama K, Sangai T, Maeda H, et al: Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers. Clin Cancer Res. 11:3494–3502. 2005. View Article : Google Scholar
58	Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, Mass R, Perrou B, Nelson B and Novotny WF: Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol. 23:3697–3705. 2005. View Article : Google Scholar : PubMed/NCBI
59	Yoo PS, Lopez-Soler RI, Longo WE and Cha CH: Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer. 6:202–207. 2006. View Article : Google Scholar : PubMed/NCBI
60	Kindler HL, Friberg G, Singh DA, Locker G, Nattam S, Kozloff M, Taber DA, Karrison T, Dachman A, Stadler WM and Vokes EE: Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 23:8033–8040. 2005. View Article : Google Scholar : PubMed/NCBI
61	Ellis LM, Curley SA and Grothey A: Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol. 23:4853–4855. 2005. View Article : Google Scholar : PubMed/NCBI
62	Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M and Bruns CJ: Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res. 10:8028–8036. 2004. View Article : Google Scholar : PubMed/NCBI